Aspirin Resistance Reversibility in Diabetic Patients
NCT01935193 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2013-09-05
Summary
The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.
Conditions
- Aspirin Resistance
Interventions
- DRUG
-
lysine acetylsalicylate
Sponsors & Collaborators
-
Azienda Ospedaliera San Giovanni Battista
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2013-08-31
Countries
- Italy
Study Locations
More Related Trials
-
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
NCT02520921 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Dosing in Diabetic Patients
NCT01201785 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT00793754 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome
NCT06716255 ·Status: COMPLETED
-
Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
NCT02933788 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
NCT05702463 ·Status: RECRUITING ·Phase: PHASE1
-
Aspirin and Clopidogrel Resistance Study
NCT01039480 ·Status: COMPLETED
-
Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease
NCT02370680 ·Status: COMPLETED ·Phase: PHASE1
-
Chronotherapy with Low-dose Aspirin for Primary Prevention
NCT00725127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
NCT03574909 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
NCT00427271 ·Status: UNKNOWN ·Phase: PHASE4
-
Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk
NCT02164578 ·Status: COMPLETED ·Phase: PHASE3
-
DS1040b/Aspirin Drug/Drug Interaction Study
NCT02071004 ·Status: COMPLETED ·Phase: PHASE1
-
ASCEND: A Study of Cardiovascular Events iN Diabetes
NCT00135226 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Danish Aspirin Resistance Trial - Pilot Study
NCT00389129 ·Status: COMPLETED ·Phase: NA
-
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
NCT05304845 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Response in High Risk Patients With Coronary Artery Disease
NCT01383304 ·Status: UNKNOWN
-
Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
NCT00129038 ·Status: COMPLETED ·Phase: PHASE4
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity
NCT02848339 ·Status: COMPLETED
-
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
NCT05247931 ·Status: UNKNOWN
-
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
NCT03174990 ·Status: COMPLETED
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Japanese Primary Prevention Project With Aspirin
NCT00225849 ·Status: UNKNOWN ·Phase: PHASE4